Real world perspective of coronary chronic total occlusion in third world countries: A tertiary care centre study

Krishna Santosh Vemuri1, Bhupinder Kumar Sihag1, Yashpaul Sharma1

  • 1Advanced Cardiac Centre, Post Graduate Institute of Medical Education and Research, PGIMER, Chandigarh, 160012, India.

Indian Heart Journal
|April 18, 2021
PubMed

Insights

Coronary chronic total occlusions (CTO) are common in Indian patients. Percutaneous coronary intervention (PCI) for CTOs shows a fair success rate in experienced centers, with age and lesion complexity predicting outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Limited data exists on the prevalence and outcomes of percutaneous coronary intervention (PCI) for coronary chronic total occlusions (CTO) in India.
  • This study addresses the gap by analyzing CTO characteristics and PCI outcomes in a North Indian tertiary referral center.

Purpose of the Study:

  • To determine the prevalence, clinical features, angiographic profile, and outcome predictors of PCI for CTOs.
  • To evaluate the success rates and factors influencing outcomes of CTO PCI in a specific Indian population.

Main Methods:

  • Retrospective analysis of 12,020 patients undergoing coronary angiography (CAG) from January 2018 to January 2019.
  • Collected detailed clinical, angiographic, and revascularization data, focusing on CTO identification and PCI outcomes.
  • Analyzed baseline parameters to identify predictors of CTO PCI success and complications.

Main Results:

  • CTO prevalence was 16.3% among all CAG patients and 24.4% in those with significant coronary artery disease (CAD).
  • The left anterior descending (LAD) artery was most commonly affected (48%), followed by the right coronary artery (RCA) (42.9%).
  • PCI success rate was 74.6% in 456 attempted CTOs. Increasing age, male sex, CTO in the left circumflex (LCx) artery, and higher J-CTO scores predicted poorer outcomes.

Conclusions:

  • Coronary chronic total occlusions are frequently encountered during coronary angiography.
  • Percutaneous coronary intervention for CTOs can achieve a fair success rate in high-volume, experienced centers, though outcomes are influenced by patient and lesion-specific factors.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
120
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
68
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
105
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
588
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
152
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
442